|
|
Volumn 286, Issue 1-2, 2008, Pages 69-74
|
|
Pasireotide (SOM230): Development, mechanism of action and potential applications
|
|
Author keywords
Acromegaly; Carcinoid tumors; Cushing's disease; Pasireotide; SOM230
|
|
Indexed keywords
CORTICOTROPIN;
GROWTH HORMONE;
PASIREOTIDE;
SOMATOSTATIN 14;
SOMATOSTATIN RECEPTOR;
SOMATOSTATIN RECEPTOR 2;
ACROMEGALY;
ARTICLE;
BINDING AFFINITY;
CELL PROLIFERATION;
CUSHING DISEASE;
DOWN REGULATION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
HORMONE RELEASE;
HUMAN;
NONHUMAN;
PRADER WILLI SYNDROME;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
TACHYPHYLAXIS;
ACROMEGALY;
ADRENOCORTICOTROPIC HORMONE;
ANIMALS;
ANTINEOPLASTIC AGENTS, HORMONAL;
CARCINOID TUMOR;
DRUG RESISTANCE, NEOPLASM;
GROWTH HORMONE;
HUMANS;
INSULIN-LIKE GROWTH FACTOR I;
OCTREOTIDE;
PITUITARY ACTH HYPERSECRETION;
RECEPTORS, SOMATOSTATIN;
SOMATOSTATIN;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
|
EID: 43549111835
PISSN: 03037207
EISSN: None
Source Type: Journal
DOI: 10.1016/j.mce.2007.09.006 Document Type: Article |
|
Times cited : (253)
|
|
References (36)
|
